The global knee reconstruction devices market is expected to reach a market valuation of US$ 8.5 billion by 2023, accelerating with a moderate CAGR of 4.3% from 2023 to 2033. The knee reconstruction devices market is anticipated to be valued at about US$ 13.0 billion by 2033 end.
According to FMI's analysis, the global knee reconstruction devices market has been expanding rapidly due to product design and functionality innovations. The knee reconstruction devices market participants have benefited from the prevalence of ailments like arthritis and knee discomfort. Furthermore, critical regulatory authorities worldwide have relaxed authorizations to provide better market access.
Innovative and effective knee repair methods and gadgets have been made possible by the rapid development of healthcare technology in recent years. Market shifts are also being driven by rising demand for minimally invasive procedures. Surgical procedure and instrument advancements have had a major impact on the current knee reconstruction devices industry.
The demand for knee reconstruction devices is expected to rise because of technological improvements and the rising prevalence of orthopedic disorders leading to an increase in surgeries. The expanding patient pool and increased prevalence of lifestyle-related illnesses are also contributing to the knee reconstruction devices market's expansion. It has been determined that the reconstruction of the hip or knee is not an emergency during the current COVID-19 pandemic.
As the number of companies producing knee reconstructive devices continues to grow, competition in the industry is heating up. Companies also plan to pour resources into R&D for new and improved products to remain competitive. The knee reconstruction devices industry is making larger bets on emerging technologies like 3D printing.
The newest innovations are more cost-effective and take advantage of mobile apps that help doctors keep tabs on evolving data in real time and provide improved patient care. All these advantages are expected to increase demand for knee reconstruction devices, driving the market forward during the forecasted time frame. Growth in the knee reconstruction devices market is predicted to be aided by the increased availability of newer, more advanced equipment for both healthcare providers and their patients.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Reduced surgical time is a direct outcome of the increased precision and accuracy made possible by minimally invasive approaches to knee reconstruction. Modern surgical techniques have bolstered demand for knee reconstruction devices, greatly reducing the complications plaguing older procedures. It is a major component fuelling the worldwide market expansion for knee reconstruction devices.
To increase performance with fewer incisions and complications, knee reconstruction surgery is receiving more funding for research and development. Trust in the gadgets and treatments is boosted by the availability of such items, which is expected to fuel knee reconstruction devices market expansion in the upcoming years. Increases in knee injuries and the need for reconstruction drive growth in the global knee reconstruction devices market.
Meanwhile, government investments in healthcare infrastructure have helped knee reconstructive technologies gain significant traction in healthcare systems worldwide. However, producers confront many hurdles that could ultimately slow the knee reconstruction devices industry's progress over the long run.
Knee reconstructive devices are prohibitively expensive, which slows their widespread use. Knee replacement and reconstruction tools competition in the market is hampered by the need to comply with increasingly stringent rules established by agencies like the Food and Drug Administration. In addition, postoperative complications, particularly those related to biocompatibility, will likely continue to worry market participants for the foreseeable future.
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 4.3% |
| Market Valuation (2023) | US$ 8.5 billion |
| Market Valuation (2033) | US$ 13.0 billion |
| Countries | Forecast Period Share Between 2023 to 2033 |
|---|---|
| United States | 29.5% |
| Germany | 8.1% |
| Japan | 5.0% |
| Countries | Forecast Period CAGR Between 2023 to 2033 |
|---|---|
| Australia | 4.4% |
| China | 4.0% |
| India | 3.8% |
| United Kingdom | 3.4% |
Principal Consultant
There is a moderate market concentration in the knee reconstruction devices industry worldwide, with a few companies expected to account for most sales. Market leaders are putting more resources into Research and Development to create innovative products and gain approval from regulators more quickly to increase their knee reconstruction devices' market share.
Recent Developments
As part of their work on a digital surgery platform that uses linked technologies, Johnson & Johnson Medical Devices Company (J&JMD) announced in January 2021 that the FDA had granted permission for their VELYS Robotic-assisted solution for use with their Attune Total Knee System.
Active Technologies received FDA clearance in March 2021 for its Citrespline and Citrelock ligament reconstruction devices, intended to prevent soft tissue damage during insertion. These devices can be used for reconstructive procedures on various joints, including the knee.
Furthermore, Conformis Inc. stated that its patient-specific iTotal PS total knee replacement system had been approved by the Therapeutic Goods Administration in Australia. This technology is intended to provide patients with reconstructive processes unique to their bodies.
The Next Generation Of Joint Replacement Safety
Joint replacement surgeries are now safer and last longer than ever before because of the widespread adoption of 3D printing.
Greater than a million people in the United States alone have total joint replacements done each year. The aging of the population and the subsequent decrease in the average age at which these procedures are performed contribute to this rising trend. By the year 2030, it is expected that four million Americans are expected to have joint replacement surgery yearly.
Replacement of a damaged joint is the best option for people with advanced arthritis in terms of both cost and clinical outcomes, but it is not without its drawbacks. Whether or not a patient experiences any post-operative joint pain, how well the replacement common functions, and how long it lasts can all be affected by seemingly minor differences in implant placement and fit.
Computer modeling software and 3D printing are being used for the first time by surgeons in Yale's Department of Orthopaedics and Rehabilitation to better prepare for and carry out joint replacements. The devices help older people recover more quickly and safely and improve outcomes.
As the technology progresses, global knee reconstruction devices market players are adopting new trends to change the outlook.
A novel AI-based solution for 3D Reconstruction of knees from X-ray images was recently announced by RSIP Vision, a developer of AI and computer vision technologies. This technology offers doctors an in-depth 3D model of each bone, which can be used for pre-operative planning and implant sizing.
It is expected to streamline doctors' procedures and reduce unnecessary expenses and radiation exposure. The doctors are likely to have a highly accurate 3D anatomical model of the patient's knee for pre-operative planning and customizing the implant.
| Attributes | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Countries Covered | United States, United Kingdom, Japan, India, China, Australia, Germany |
| Key Segments Covered | Product Type, End User, Indication, Region |
| Key Companies Profiled | Zimmer, Inc.; Stryker Corporation; DePuy Synthes; Smith & Nephew; Corin; United Orthopedic Corporation; Arthrex Inc.; Exactech Inc.; DJO Global; Japan Medical Dynamic Marketing; Tornier Inc. |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The growth potential of the market is 4.3% through 2033.
The United States is projected to emerge as a lucrative market.
The need to comply with increasingly stringent rules hampers the market.
China's market is projected to expand at 4% CAGR by 2033.
Reduced surgical time is a direct outcome of the increased precision driving sales in the market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033 5.3.1. Cemented Implants 5.3.2. Cementless Implants 5.3.3. Partial Implants 5.3.4. Revision Implants 5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033 6.3.1. Hospitals 6.3.2. Orthopedic Clinics 6.3.3. ASCs 6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Indication, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033 7.3.1. Osteoarthritis 7.3.2. Rheumatoid Arthritis 7.3.3. Trauma 7.3.4. Others 7.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Product 9.2.3. By End User 9.2.4. By Indication 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By End User 9.3.4. By Indication 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product 10.2.3. By End User 10.2.4. By Indication 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By End User 10.3.4. By Indication 10.4. Key Takeaways 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. U.K. 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Product 11.2.3. By End User 11.2.4. By Indication 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By End User 11.3.4. By Indication 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Product 12.2.3. By End User 12.2.4. By Indication 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By End User 12.3.4. By Indication 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Product 13.2.3. By End User 13.2.4. By Indication 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By End User 13.3.4. By Indication 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product 14.2.3. By End User 14.2.4. By Indication 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By End User 14.3.4. By Indication 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product 15.2.3. By End User 15.2.4. By Indication 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By End User 15.3.4. By Indication 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product 16.1.2.2. By End User 16.1.2.3. By Indication 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product 16.2.2.2. By End User 16.2.2.3. By Indication 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product 16.3.2.2. By End User 16.3.2.3. By Indication 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product 16.4.2.2. By End User 16.4.2.3. By Indication 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product 16.5.2.2. By End User 16.5.2.3. By Indication 16.6. U.K. 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product 16.6.2.2. By End User 16.6.2.3. By Indication 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product 16.7.2.2. By End User 16.7.2.3. By Indication 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product 16.8.2.2. By End User 16.8.2.3. By Indication 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product 16.9.2.2. By End User 16.9.2.3. By Indication 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product 16.10.2.2. By End User 16.10.2.3. By Indication 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product 16.11.2.2. By End User 16.11.2.3. By Indication 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product 16.12.2.2. By End User 16.12.2.3. By Indication 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product 16.13.2.2. By End User 16.13.2.3. By Indication 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product 16.14.2.2. By End User 16.14.2.3. By Indication 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product 16.15.2.2. By End User 16.15.2.3. By Indication 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Product 16.16.2.2. By End User 16.16.2.3. By Indication 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Product 16.17.2.2. By End User 16.17.2.3. By Indication 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Product 16.18.2.2. By End User 16.18.2.3. By Indication 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Product 16.19.2.2. By End User 16.19.2.3. By Indication 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Product 16.20.2.2. By End User 16.20.2.3. By Indication 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Product 16.21.2.2. By End User 16.21.2.3. By Indication 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Product 16.22.2.2. By End User 16.22.2.3. By Indication 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Product 16.23.2.2. By End User 16.23.2.3. By Indication 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product 17.3.3. By End User 17.3.4. By Indication 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Zimmer, Inc. 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. Stryker Corporation 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. DePuy Synthes 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Smith & Nephew 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Corin 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Value (US$ Million) & Volume (Units)ed Orthopedic Corporation 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. Arthrex Inc. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Exactech Inc. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. DJO Global 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. Japan Medical Dynamic Marketing 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 18.1.11. Tornier Inc. 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.11.5.2. Product Strategy 18.1.11.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Knee Reconstruction Devices Market
